UBS Group’s HCW Biologics HCWB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.7K | Buy |
+9,518
| New | +$37.7K | ﹤0.01% | 6707 |
|
|
2024
Q4 | – | Sell |
-121
| Closed | -$2.6K | – | 8827 |
|
|
2024
Q3 | $2.6K | Buy |
121
+14
| +13% | +$301 | ﹤0.01% | 7188 |
|
|
2024
Q2 | $2.77K | Buy |
107
+92
| +613% | +$2.38K | ﹤0.01% | 7141 |
|
|
2024
Q1 | $1.06K | Sell |
15
-1
| -6% | -$71 | ﹤0.01% | 7070 |
|
|
2023
Q4 | $778 | Buy |
16
+11
| +220% | +$535 | ﹤0.01% | 7300 |
|
|
2023
Q3 | $403 | Buy |
+5
| New | +$403 | ﹤0.01% | 7372 |
|
|
2023
Q2 | – | Hold |
0
| – | -$22 | – | 8045 |
|
|
2023
Q1 | – | Sell |
-10
| Closed | -$732 | – | 8310 |
|
|
2022
Q4 | $732 | Buy |
+10
| New | +$732 | ﹤0.01% | 8887 |
|
|
2022
Q3 | – | Sell |
-51
| Closed | -$5K | – | 9396 |
|
|
2022
Q2 | $5K | Buy |
51
+8
| +19% | +$784 | ﹤0.01% | 7836 |
|
|
2022
Q1 | $5K | Buy |
+43
| New | +$5K | ﹤0.01% | 8069 |
|
|
2021
Q4 | – | Sell |
-935
| Closed | -$119K | – | 9216 |
|
|
2021
Q3 | $119K | Buy |
+935
| New | +$119K | ﹤0.01% | 4638 |
|